Clinical Trial Information Request for Protocol 21-622 Title A Phase II study evaluating loncastuximab tesirine in patients with previously treated Waldenström Macroglobulinemia PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone